Karas Eric sold SPRY
July 1, 2025 · Form 4 insider transaction
Karas Eric sold 15,000 shares of ARS Pharmaceuticals, Inc. at $16.99 per share, a transaction worth $254.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$16.99
Total value
$254.9K
InsiderKaras Eric
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 1, 2025
Filing dateJuly 3, 2025
Shares owned after10,315
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024.; The weighted average sale price for the transaction reported was $16.9907, and the range of prices were between $16.71 and $17.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.